Rationale
Chlamydia, gonorrhea, syphilis, and HIV screening should be ordered.
According to the USPSTF recommendations, sexually active individuals, particularly those engaging in risky behaviors, should undergo screening for chlamydia, gonorrhea, syphilis, and HIV to ensure early detection and treatment of STIs.
A) Chlamydia, gonorrhea, and cervical cancer screening
This option omits syphilis and HIV screening, which are critical for patients with risky sexual behaviors. While chlamydia and gonorrhea screenings are important, cervical cancer screening is not universally recommended for individuals under 21, as it is not part of the standard STI screening protocol.
B) Syphilis, HIV, and cervical cancer screening
Although this choice includes syphilis and HIV screenings, it fails to include chlamydia and gonorrhea, which are also necessary for comprehensive STI screening in sexually active individuals. Additionally, cervical cancer screening is not recommended for young adults in this context.
C) Chlamydia, gonorrhea, syphilis, HIV, and cervical cancer screening
While this option includes important screenings, it unnecessarily adds cervical cancer screening, which is not recommended for individuals under 21 and does not align with the specific USPSTF guidelines for STI screening in this age group.
Conclusion
For a 20-year-old patient with risky sexual behaviors, the most appropriate screenings, according to USPSTF recommendations, are chlamydia, gonorrhea, syphilis, and HIV. These screenings are essential for early detection and management of STIs, thus ensuring better health outcomes. Other screenings, such as cervical cancer testing, are not indicated in this specific age group and context, highlighting the importance of tailored screening protocols.